-5%
Revert Tablet belongs to a group of anti-vertigo drugs used to treat the symptoms of vertigo, such as dizziness, spinning sensation, nausea, and vomiting.
Revert Tablet is a combination of two active ingredients: Cinnarizine and Dimenhydrinate. Cinnarizine is classified as a calcium channel blocker, while Dimenhydrinate belongs to the antihistamine class of drugs. Together, they provide symptomatic relief for vertigo associated with Benign Paroxysmal positional vertigo (BPPV) and migraine in adults who have not responded to alternative treatments.
However, there are certain precautions and contraindications associated with the use of Revert Tablet:
- Revert Tablet is not recommended for use in patients with severe kidney and liver issues. Patients with these conditions should consult their doctor before taking the medication.
- Patients with severe heart disease or lung conditions such as asthma or emphysema should inform their doctor before using Revert Tablet.
- Revert Tablet is not recommended for use during pregnancy due to potential risks to the fetus. Pregnant women should seek medical advice before taking this medication. It is also not recommended for breastfeeding women as it may pass through breast milk to the infant.
- Revert Tablet is not recommended for use in children and adolescents under 18 years of age.
- In elderly patients aged 65 years or above, Revert Tablet should be used with caution. It is advisable to consult a doctor before taking the medication.
- Common side effects of Revert Tablet include drowsiness, dry mouth, headache, and stomach pain. If any of these symptoms worsen, patients should contact their doctor.
As with any medication, it is essential to follow the doctor’s advice and discuss any pre-existing medical conditions or concerns before starting Revert Tablet to ensure safe and effective treatment.